Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (66)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Allamand, V.
Right arrow Articles by Campbell, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allamand, V.
Right arrow Articles by Campbell, K. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 16 2459-2467
© 2000 Oxford University Press

Animal models for muscular dystrophy: valuable tools for the development of therapies

Valérie Allamand and Kevin P. Campbell+

Howard Hughes Medical Institute, Department of Physiology and Biophysics and Department of Neurology, University of Iowa College of Medicine, 400 Eckstein Medical Research Building, Iowa City, IA 52242, USA

Since the identification of dystrophin as the causative factor in Duchenne muscular dystrophy, an increasing amount of information on the molecular basis of muscular dystrophies has facilitated the division of these heterogeneous disorders into distinct groups. As more light is being shed on the genes and proteins involved in muscular dystrophy, diagnosis of patients has improved enormously. In addition to naturally occurring animal models, a number of genetically engineered murine models for muscular dystrophy have been generated. These animal models have provided valuable clues to the understanding of the pathogenesis of these disorders. Furthermore, as therapeutic approaches are being developed, mutant animals represent good models in which they can be tested. The present review focuses on the recent advancements of gene transfer-based strategies, with a special emphasis on animal models for Duchenne and limb-girdle muscular dystrophies.

+ To whom correspondence should be addressed. Tel: +1 319 335 7867; Fax: +1 319 335 6957; Email: kevin-campbell@uiowa.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
H. Li, A. Mittal, D. Y. Makonchuk, S. Bhatnagar, and A. Kumar
Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy
Hum. Mol. Genet., July 15, 2009; 18(14): 2584 - 2598.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Periasamy and J. A. Rafael-Fortney
Somatic gene therapy to treat heart failure is one step closer to reality
Cardiovasc Res, June 1, 2009; 82(3): 383 - 384.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Hoshijima
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1313 - H1325.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. van Lunteren, M. Moyer, and P. Leahy
Gene expression profiling of diaphragm muscle in {alpha}2-laminin (merosin)-deficient dy/dy dystrophic mice
Physiol Genomics, March 13, 2006; 25(1): 85 - 95.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
R. M Lovering, N. C Porter, and R. J Bloch
The Muscular Dystrophies: From Genes to Therapies
Physical Therapy, December 1, 2005; 85(12): 1372 - 1388.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Jefferies, B. W. Eidem, J. W. Belmont, W. J. Craigen, S. M. Ware, S. D. Fernbach, S. R. Neish, E. O. Smith, and J. A. Towbin
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Circulation, November 1, 2005; 112(18): 2799 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Ho, C. M. Post, L. R. Donahue, H. G.W. Lidov, R. T. Bronson, H. Goolsby, S. C. Watkins, G. A. Cox, and R. H. Brown Jr
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency
Hum. Mol. Genet., September 15, 2004; 13(18): 1999 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. J. Allikian, A. A. Hack, S. Mewborn, U. Mayer, and E. M. McNally
Genetic compensation for sarcoglycan loss by integrin {alpha}7{beta}1 in muscle
J. Cell Sci., August 1, 2004; 117(17): 3821 - 3830.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. V. Chakkalakal, M.-A. Harrison, S. Carbonetto, E. Chin, R. N. Michel, and B. J. Jasmin
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice
Hum. Mol. Genet., February 15, 2004; 13(4): 379 - 388.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. I. Bassett and P. D. Currie
The zebrafish as a model for muscular dystrophy and congenital myopathy
Hum. Mol. Genet., October 15, 2003; 12(90002): R265 - 270.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. K. Grewal and J. E. Hewitt
Glycosylation defects: a new mechanism for muscular dystrophy?
Hum. Mol. Genet., October 15, 2003; 12(90002): R259 - 264.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Paturneau-Jouas, E. Parzy, G. Vidal, P. G. Carlier, C. Wary, J.-T. Vilquin, E. de Kerviler, K. Schwartz, and A. Leroy-Willig
Electrotransfer at MR Imaging: Tool for Optimization of Gene Transfer Protocols--Feasibility Study in Mice
Radiology, September 1, 2003; 228(3): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Mayer
Integrins: Redundant or Important Players in Skeletal Muscle?
J. Biol. Chem., April 18, 2003; 278(17): 14587 - 14590.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Yi, J. M. Bekker, G. Miller, K. L. Hill, and R. H. Crosbie
Specific and Potent RNA Interference in Terminally Differentiated Myotubes
J. Biol. Chem., January 3, 2003; 278(2): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. H. CROSBIE, R. BARRESI, and K. P. CAMPBELL
Loss of sarcolemma nNOS in sarcoglycan-deficient muscle
FASEB J, November 1, 2002; 16(13): 1786 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Physiol Rev, April 1, 2002; 82(2): 291 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Culligan, N. Banville, P. Dowling, and K. Ohlendieck
Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle
J Appl Physiol, February 1, 2002; 92(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M.T. WHEELER, M.J. ALLIKIAN, A. HEYDEMANN, and E.M. MCNALLY
The Sarcoglycan Complex in Striated and Vascular Smooth Muscle
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 389 - 398.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. Bonner and T. P. O'Connor
The Permissive Cue Laminin Is Essential for Growth Cone Turning In Vivo
J. Neurosci., December 15, 2001; 21(24): 9782 - 9791.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. De Repentigny, P. D. Cote, M. Pool, G. Bernier, S. Girard, S. M. Vidal, and R. Kothary
Pathological and genetic analysis of the degenerating muscle (dmu) mouse: a new allele of Scn8a
Hum. Mol. Genet., August 1, 2001; 10(17): 1819 - 1827.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.